Pentwater Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Pentwater Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-130,000	Closed	-$12.1M	–	250
2021 Q4	$12.1M	Buy	+130,000	New	+$8.56M	0.13%	56

Pentwater Capital Management's ARNA Position: Q1 2022 in Review

Pentwater Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 130,000 shares — an estimated $12.1M sold.

Pentwater Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $12.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Pentwater Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Pentwater Capital Management sold 130,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $12.1M.
Pentwater Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Pentwater Capital Management's Arena Pharmaceuticals Inc position peaked at $12.1M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Pentwater Capital Management's 13F filing for Q1 2022, filed 16 May 2022.